Patient-Specific Access For Locally Unlicensed Therapies
When a therapy is approved somewhere in the world but not marketed locally, treatment plans face a gap. Individual Import closes that gap by converting external approvals into named-patient access.
Individual Import is the bridge between global innovation and local care. In settings where suitable local options are absent, approved therapies from other regions become additional choices for individual patients.
When a medicine exists but isn’t available locally, Individual Import enables compliant, patient-specific access so treatment can proceed without waiting for commercialization.
Need a Product?
Tell us what you're looking for and we'll route your inquiry to the right team.
Whether it's a comparator, ancillary supply, unlicensed medicine, named patient request or a specific product requirement, we'll review your inquiry and respond with the most appropriate solution.
About Individual Import
A true extension of therapeutic choice, Individual import creates another chance for the patient.
Access to global innovation
Case-by-case access to therapies approved in other regions when local options are absent or unsuitable.Clinically governed, patient-first
Access grounded in medical need and aligned with hospital committees for transparent, defensible decisions.Transparent cost & procurement fit
Upfront quotes compatible with hospital purchasing and budget workflows.Supply Optimization
Optimization for accelerated lead time on routinely imported products.
Selected Individual Import Capabilities
Why Komtur?
Patient-First, Care-Centric Handling
Single case owner, transparent status, and checklist documentation help keep cases moving and care continuous.
Speed with Certainty
Bonded-warehouse release, established customs and Importer of Record (IOR) workflows, and temperature-controlled last-mile delivery to hospital or pharmacy receipt.
Licensed Global Access Network
Quality-assured sourcing with falsified-medicines safeguards, serialization, and end-to-end batch traceability.
Authority-Aligned, Multi-Country Enablement
Correct use of named-patient and shortage pathways, plus practical broker and IOR guidance as well as documentation support.
Proactive Access Insights
Continuous shortage and regulatory-approval monitoring, demand validation, and early qualification of alternatives to protect continuity of care.
We understand that behind every order is a patient in need, and have built our process to deliver on that.
Related Treatment Access Solutions
Shortage ResolutionRestore continuity of care during supply disruptions. Proactive market scanning, authority collaboration, qualified alternatives, and controlled distribution to keep care sites supplied.
A medicine to find. A challenge to solve.
Tell us what you need. We’ll help assess the options and work out the next step.
Tell us what you're looking for and we'll route your inquiry to the right team.
Whether it's a comparator, ancillary supply, unlicensed medicine, named patient request or a specific product requirement, we'll review your inquiry and respond with the most appropriate solution.
Tell us what you’re working through and we’ll connect you with the right specialist.
Whether you're planning market entry, managing ongoing supply, responding to a shortage, designing an access program or exploring a commercial partnership, our specialists are here to help.
PLEASE NOTE: Access and supply are assessed case by case and are subject to applicable local laws, regulatory requirements and product availability. Approval in another country does not automatically permit local import or use. Clinical decisions remain with the responsible healthcare professionals.